Christine Signore, MD

NPI 1760538334ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Middletown, CT

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Middletown, Connecticut, trained at Boston University School of Medicine (class of 2003). Their prescriptions cost Medicare Part D more than their services did: $1,696,711 for 4,255 claims, against $125,789 paid for services in 2024. Amgen Inc. was the largest of 2 companies reporting payments in 2025, $341.89 in all, mostly food and beverage.

Overview

NPI	1760538334
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Jan 26, 2007
Last updated in NPPES	Feb 4, 2026
Certified by provider	Feb 4, 2026

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary	207RE0101X	044466	CT
Internal Medicine	207R00000X	044468	CT

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Endocrinology (CT)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	256
Services billed	4,206 across 16 procedure codes
Paid by Medicare	$125,789

Part D prescriptions in 2024

Prescriptions (claims)	4,255 · 10,558 30-day fills
Patients	560
Total drug cost	$1,696,711
Generic share	41% of claims

Medicare sources and data years

Education and affiliations

Medical school	Boston University School of Medicine
Graduation year	2003
Medicare specialty	Endocrinology
Secondary specialties	Internal Medicine
Telehealth	Offers telehealth